The FDA has decided not to approve vusolimogene oderparepvec (RP1) in combination with nivolumab for advanced melanoma.

The US Food and Drug Administration (FDA) has instructed all GLP-1 drug-makers to update their warning labels to include the ...

In a complete response letter, the FDA indicates the drug trial is not an adequate, well-controlled clinical investigation, ...

Bureaucratic bottlenecks and high regulatory costs at the Food and Drugs Authority (FDA) are discouraging many small- and ...

The FDA's generative AI, Elsa, has a massive hallucination problem, according to the agency's employees themselves.

Sarepta Therapeutics (SRPT) stock drops as the company faces potential FDA-mandated studies after safety concerns over its ...

The mind-expanding drugs may help heal many mental health conditions. But studies haven’t actually proved that yet.

FDA extends Blenrep combo review to October to assess more data from Phase 3 trials in relapsed or refractory multiple myeloma.

On April 10, 2025, the U.S. Food and Drug Administration (FDA) announced a landmark initiative to phase out animal testing in ...

You'll get access to an ad-free website with a faster photo browser, the chance to claim free tickets to a host of events ...

An FDA panel meeting featured a heated dialogue over whether fluoride supplements could pose health risks to children. Here's ...

The East Baton Rouge Metro Council approved to increase higher fines and penalties to businesses and bars who serve alcohol to minors. The age range decreases to 17 and under.